GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Li Kang Biomedical Co 6242.TWO · TWD

Consumer Staples · Taipei Exchange · 🇹🇼 Taiwan

Compare

31.50

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Li Kang Biomedical Co

Its shares trade on Taipei Exchange under the ticker 6242.TWO. It has been listed since 18 June 2002. In the fiscal year to 31 December 2025, it reported revenue of TWD 589.2m and net income of TWD 83.8m. At that date it held total assets of TWD 1.09bn and shareholders' equity of TWD 871.2m.

Li Kang Biomedical Co. Ltd. engages in the tourism businesses, telemarketing as well as the manufacturing and sales of cosmetics and hygienic drinks. The company is headquartered in Tainan, Tainan. The company went IPO on 2002-06-18. The firm offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The firm distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
18 Jun 2002

Leadership

Pay as last reported

  • Yuxiu ZhengChairman of the Board, General Manager
  • Liyu LinFinance Manager, Corporate Governance Officer, since 2023
  • Mingju ChenDeputy General Manager
  • Zhonghua HeDeputy General Manager
  • Yayi HuangDirector
  • Huiqian LiDirector
  • Hongyuan LinDirector
  • Huiyuan ZhangDirector
  • Jianping ZhangDirector
  • Zhichang ChenIndependent Director
  • Zhilin ChenIndependent Director
  • Ms. Shiying HuangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Li Kang Biomedical Co Ltd manufactures UTP cables and USB cables for global markets.
  • The company distributes products in Europe, the Americas, and Asia with strong domestic presence.
  • Li Kang Biomedical offers hygienic drinks and cosmetics under Consumer Staples sector.

Weaknesses

  • Li Kang Biomedical focuses on tourism and telemarketing, which may distract from core products.
  • The firm's business description includes unverified tourism operations in its sector.
  • Manufacturing of cables and communication systems may face high competition in Asia.

Opportunities

  • Expanding into Europe and the Americas for cable and communication system sales.
  • Growing demand for hygienic drinks in the Consumer Staples sector.
  • Increasing global demand for wireless vehicle communication systems in Asia.

Threats

  • Competition from cable manufacturers in the Asia market.
  • Regulatory changes affecting tourism and telemarketing businesses.
  • Economic downturns impacting consumer spending on cosmetics and drinks.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.